Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19
Medicine
[키워드] acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
adverse event
aggravate
Almitrine
ARDS
baseline
Combination
coronavirus
coronavirus disease
COVID-19
criteria
defined
Endothelial dysfunction
hypertension
Hypoxemia
hypoxic
ICU
inclusion criteria
Inflammation
infused
Inhaled
intensive care
manifested
mechanical ventilation
moderate
nitric oxide
Open-label
Oxide
oxygen
Oxygenation
PaO
Paris
Patient
patients
PPM
Protective
SARS-CoV-2
severe ARDS
severe hypoxemia
single-center
study period
syndrome
therapy
vasoactive drug
vasoconstriction
Ventilation
[DOI] 10.3389/fmed.2021.655763 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.655763 PMC 바로가기 [Article Type] Medicine